178 related articles for article (PubMed ID: 21543761)
1. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
Guadagnoli M; Kimberley FC; Phan U; Cameron K; Vink PM; Rodermond H; Eldering E; Kater AP; van Eenennaam H; Medema JP
Blood; 2011 Jun; 117(25):6856-65. PubMed ID: 21543761
[TBL] [Abstract][Full Text] [Related]
2. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
3. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
4. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
6. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
[TBL] [Abstract][Full Text] [Related]
7. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
9. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
10. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
11. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
Rickert RC; Jellusova J; Miletic AV
Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
[TBL] [Abstract][Full Text] [Related]
12. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
13. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
14. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
[TBL] [Abstract][Full Text] [Related]
15. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
18. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
Xu S; Lam KP
Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
[TBL] [Abstract][Full Text] [Related]
19. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
20. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
